Drug Manufacturers—General Stocks
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12 |  LLY Eli Lilly and Company Common Stock | 1169.93 USD | -1.55% | +1.53% | +3.99% | +36.50% | 1.10 T USD | ||
| 20 |  JNJ Johnson & Johnson Common Stock | 256.49 USD | -0.71% | -1.00% | -5.18% | +33.58% | 618.11 B USD | ||
| 23 |  ABBV AbbVie Inc. Common Stock | 272.42 USD | +0.41% | +5.17% | +8.43% | +17.57% | 481.40 B USD | ||
| 35 |  MRK Merck & Company, Inc. Common Stock | 142.40 USD | -0.25% | -0.95% | -3.66% | +62.21% | 351.33 B USD | ||
| 47 |  NVS Novartis AG | 143.12 USD | -0.10% | +1.18% | +3.13% | +8.58% | 273.09 B USD | ||
| 66 |  AMGN Amgen Inc. - Common Stock | 407.44 USD | -1.37% | -0.66% | +5.05% | +37.57% | 220.28 B USD | ||
| 82 |  GILD Gilead Sciences, Inc. - Common Stock | 147.10 USD | +0.17% | -0.41% | +1.40% | +25.27% | 182.40 B USD | ||
| 99 |  PFE Pfizer, Inc. Common Stock | 27.83 USD | -0.57% | -0.96% | +0.29% | +10.04% | 158.62 B USD | ||
| 125 |  BMY Bristol-Myers Squibb Company Common Stock | 59.56 USD | -0.20% | -2.28% | -8.11% | +33.72% | 121.66 B USD | ||
| 154 |  GSK GSK plc American Depositary Shares | 46.52 USD | -1.06% | -1.13% | -4.02% | +6.09% | 100.38 B USD | ||
| 161 |  SNY Sanofi - American Depositary Shares | 40.23 USD | +0.07% | +1.46% | -6.14% | -17.86% | 98.12 B USD | ||
| 371 |  ONC BeOne Medicines Ltd - American Depositary Shares | 350.13 USD | -3.82% | -0.38% | +2.51% | +10.91% | 39.81 B USD | ||
| 423 |  BIIB Biogen Inc. - Common Stock | 218.43 USD | -1.67% | -1.98% | +4.05% | +45.62% | 32.27 B USD | ||
| 1220 |  CGON CG Oncology, Inc. - Common stock | 63.26 USD | +1.41% | -8.78% | -10.79% | +45.22% | 5.61 B USD | ||
| 1264 |  MANE Veradermics, Incorporated Common Stock | 126.68 USD | +13.94% | +5.28% | +28.57% | +283.88% | 5.29 B USD | ||
| 1286 |  ORKA Oruka Therapeutics, Inc. - Common Stock | 77.28 USD | -2.79% | -9.66% | -14.33% | +140.97% | 5.12 B USD | ||
| 1534 |  OGN Organon & Co. Common Stock | 13.76 USD | -0.15% | +0.29% | +0.73% | +89.53% | 3.61 B USD | ||
| 1780 |  MBX MBX Biosciences, Inc. - Common Stock | 53.25 USD | -2.37% | -10.17% | -14.70% | +234.91% | 2.56 B USD | ||
| 1985 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 131.34 USD | +0.57% | -2.82% | -11.51% | +77.85% | 1.89 B USD | ||
| 2025 |  GENB Generate Biomedicines, Inc. - Common Stock | 13.99 USD | +3.10% | +0.43% | -8.68% | -6.73% | 1.80 B USD |
ニュース Drug Manufacturers—General Stocks
「ロシア、シベリアで2件目の感染報告を否定」 - Bloomberg
サミット・セラピューティクス、アストラゼネカ、第一三共、TROP2標的ADC「Datroway」とIvonescimabを複数の腫瘍タイプで評価する臨床試験提携を発表、まずは第III相の一次治療トリプルネガティブ乳がん試験から開始
イーライリリーとの提携終了後、Foghorn Therapeuticsが開発パイプラインを転換
ドナルド・トランプとキャシー・ウッドが同じ32銘柄に賭ける――驚くものもあるかもしれない
Invivyd、COVID-19抗体に関するFDAへの迅速承認申請の道筋を示す
オルガノン・カナダは、中等度から重度のアトピー性皮膚炎を治療するためのNDUVRAの販売を発表します。
本日のセッションでクジラアラートを出した10の医療株
Gainers Drug Manufacturers—General Stocks
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0497 | +34.32% |
MANE Veradermics, Incorporated Common Stock | 126.68 | +13.94% |
 OSTX OS Therapies Incorporated Common Stock | 1.62 | +5.88% |
 KAPA Kairos Pharma, Ltd. Common Stock | 0.93 | +5.68% |
 CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 | +4.67% |
GENB Generate Biomedicines, Inc. - Common Stock | 13.99 | +3.10% |
 QCLS Q/C Technologies, Inc. - Common Stock | 0.64 | +1.59% |
CGON CG Oncology, Inc. - Common stock | 63.26 | +1.41% |
Losers Drug Manufacturers—General Stocks
 MDCX Medicus Pharma Ltd. - Common Stock | 0.10 | -37.50% |
 APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 | -22.09% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0319 | -16.05% |
 SCLX Scilex Holding Company - Common Stock | 2.96 | -15.19% |
 IBO Impact BioMedical, Inc. Common Stock | 4.12 | -9.25% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 0.47 | -6.00% |
 DCOY Decoy Therapeutics Inc. - Common Stock | 1.52 | -5.59% |
 VIVS VivoSim Labs, Inc. - Common Stock | 0.18 | -5.26% |